Felix Nizet

Felix Nizet is an experienced investment professional currently focused on the €100m European venture fund at Heal Capital, which supports innovators at the intersection of healthcare and technology. Previous roles include contributing to the Go-To-Market strategy and hardware development for the FDA cleared AI-enabled polyp detection device at Iterative Health, managing a Global Distribution Technology roadmap at MFS Investment Management, and internships in business and retail settings. Felix holds a Bachelor of Science in International Business/Trade/Commerce with dual minors in Design Engineering and Economics (Magna Cum Laude) from Northeastern University, and also completed a bachelor's degree through the Erasmus program at the ACT - American College of Thessaloniki.